Comparison of ALK, RET, and ROS1 Gene Fusion Detection by Next-Generation Sequencing, Fluorescence in situ Hybridization, and Immunohistochemistry in Non-Small Cell Lung Cancer

被引：0
|
作者：
Oran, A. [1 ]
Grubb, J. [1 ]
Lieberman, D. B. [1 ]
Sussman, R. T. [1 ]
Morrissette, J. [1 ]
Rosenbaum, J. N. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2017年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST104
引用
收藏
页码：1033 / 1033
页数：1
相关论文
共 50 条
  • [1] Comparative Efficacies of Immunohistochemistry, Fluorescence In Situ Hybridization, and Next-Generation Sequencing for NTRK Fusion Detection in Non-Small Cell Lung Cancer
    Dong, Kun
    Lin, Dongmei
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1907 - S1908
  • [2] The novel mRNA in situ hybridization method for the detection of ALK, RET, ROS1 and NTRK1 mRNA in non-small cell lung cancer
    Hirai, Noriko
    Sasaki, Takaaki
    Minami, Yoshinori
    Ohsaki, Yoshinobu
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer
    Pekar-Zlotin, Marina
    Hirsch, Fred R.
    Soussan-Gutman, Lior
    Ilouze, Maya
    Dvir, Addie
    Boyle, Theresa
    Wynes, Murry
    Miller, Vincent A.
    Lipson, Doron
    Palmer, Gary A.
    Ali, Siraj M.
    Dekel, Shlomi
    Brenner, Ronen
    Bunn, Paul A., Jr.
    Peled, Nir
    ONCOLOGIST, 2015, 20 (03): : 316 - 322
  • [4] Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non-Small Cell Lung Carcinoma
    Nambirajan, Aruna
    Sood, Ridhi
    Khatoon, Warisa
    Malik, Prabhat Singh
    Mohan, Anant
    Jain, Deepali
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (08) : 928 - 937
  • [5] Detection of ALK, RET, ROS1, NTRK1 and MET rearrangements and actionable mutations using next generation sequencing in patients with non-small cell lung cancer
    Harle, A.
    Dietmaier, W.
    Vogl, I.
    Neumann, K.
    Haumaier, F.
    Beggs, A. D.
    Pestinger, V.
    Grand, D.
    Tallet, A.
    Merlin, J-L.
    ANNALS OF ONCOLOGY, 2018, 29 : 12 - 12
  • [6] Comparison of Different ROS1 Immunohistochemistry Clones and Consistency with Fluorescence In Situ Hybridization Results in Non-Small Cell Lung Carcinoma
    Dulger, Onur
    Oz, Buge
    BALKAN MEDICAL JOURNAL, 2023, 40 (05) : 344 - 350
  • [7] Detection of ALK, RET, ROS1 Rearrangements by NanoString in Brazilian Patients with Non-small Cell Lung Cancer
    Novaes, L.
    de Paula, F.
    Evangelista, A.
    Mattos, L.
    De Marchi, P.
    Silva, C.
    Ferro, L.
    Reis, R. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 986 - 986
  • [8] Histologic and Molecular Characterization of Non-Small Cell Lung Carcinoma With Discordant ROS1 Immunohistochemistry and Fluorescence In Situ Hybridization
    Wilcock, Diane M.
    Schmidt, Robert L.
    Furtado, Larissa V.
    Matynia, Anna P.
    Deftereos, Georgios
    Sirohi, Deepika
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (01) : 19 - 26
  • [9] Clinical implementation of anchored multiplex PCR with targeted next-generation sequencing for detection of ALK, ROS1, RET and NTRK1 fusions in non-small cell lung carcinoma.
    Farago, Anna F.
    Zheng, Zongli
    Muzikansky, Alona
    Gainor, Justin F.
    Iafrate, A. John
    Engelman, Jeffrey A.
    Le, Long P.
    Shaw, Alice Tsang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Biomarkers for ALK and ROS1 in Lung Cancer Immunohistochemistry and Fluorescent In Situ Hybridization
    Luk, Peter P.
    Selinger, Christina I.
    Mahar, Annabelle
    Cooper, Wendy A.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (08) : 922 - 928
12345